References



References

  1. Dent RW Jr, Ervin DK. A study of metaxalone (Skelaxin) vs. placebo in acute musculoskeletal disorders: a cooperative study. Curr Ther Res Clin Exp. 1975;18(3):433-440.
  2. Chou R, Peterson K, Helfand M. Comparative efficacy and safety of skeletal muscle relaxants for spasticity and musculoskeletal conditions: a systematic review. J Pain Symptom Manage. 2004;28(2):140-175.
  3. Mayo Clinic. Back pain. MayoClinic Web site. http://www.mayoclinic.com/health/back-pain/DS00171. Accessed June 14, 2007.
  4. Back pain guide. WebMD Web site. http://www.webmd.com/back-pain/guide. Accessed June 14, 2007.
  5. National Institute of Arthritis and Musculoskeletal and Skin Diseases. Handout on Health: Back Pain. Bethesda, MD: NIAMS/National Institutes of Health; 2005. NIH publication 05-5282.
  6. Skelaxin [package insert]. Bristol, TN: King Pharmaceuticals, Inc; 2007.
  7. Fathie K. A second look at a skeletal muscle relaxant: a double-blind study of metaxalone. Curr Ther Res Clin Exp. 1964;6(11):677-683.
  8. Reeves RR, Algood TL, Wise PM. Skeletal muscle relaxants and associated medications for nonspecific acute back pain. Pharmacol Ther. 2005;30(9):518-527.
  9. Fielding D, Fielding S. Understanding your back. In: Back Book: Achieving and Maintaining a Healthy Back. East Sussex, England: The Ivy Press Limited; 2001:1-153.
  10. US Department of Health and Human Services, Agency For Healthcare Research and Quality. Next Steps After Your Diagnosis: Finding Information and Support. Rockville, MD: Agency for Healthcare Research and Quality; 2005. AHRQ Pub. No. 05-0049.
  11. Gross L. Metaxalone: a review of clinical experience. J Neurol Orthop Med Surg. 1998;18(1):76-79.
  12. National Pharmaceutical Council and Joint Commission on Accreditation of Healthcare Organizations. Pain: Current Understanding of Assessment, Management, and Treatments. Reston, VA: National Pharmaceutical Council; 2001.
  13. Low back pain. The Cleveland Clinic Web site. http://www.clevelandclinic.org/health/health-info/docs/0000/0048.asp?index=4371. Accessed June 14, 2007.
  14. Carroll MN Jr, Luten WR, Southward RW. The pharmacology of a new oxazolidinone with anticonvulsant, analgetic and muscle relaxant properties. Arch Int Pharmacodyn Ther. 1961;130(3-4):280-298.
  15. Simon GI. Drug therapy in the management of back pain. Occup Health Saf. 1981;50(1):10-20.
  16. Cady R, Farmer K, Schreiber C. Skeletal muscle relaxants: a new rationale for choice [special report]. Prim Care Special Ed. June 2003:1-4.